In the present study, we have identified macrophage migration inhibitory factor (MIF) as a key inflammatory cytokine potentially involved in Bone Marrow (BM) infiltration in patients with high-risk neuroblastoma (NB). This evidence concerns the gene MIF and neuroblastoma.